Autori: Demil Nacima
| Naslov | Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial (Article) |
| Autori | Rosenstock Julio Emral Rifat Sauque-Reyna Leobardo Mohan Viswanathan Trescoli Carlos Al Sifri Saud Lalic Nebojsa M Alvarez Agustina Picard Pascaline Bonnemaire Mireille Demil Nacima McCrimmon Rory J |
| Info | DIABETES CARE, (2021), vol. 44 br. 10, str. 2361-2370 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial (Article) |
| Autori | McCrimmon Rory J Al Sifri Saud Emral Rifat Mohan Viswanathan Sauque-Reyna Leobardo Trescoli Carlos Lalic Nebojsa M Alvarez Agustina Demil Nacima Coudert Mathieu Shaunik Alka Bonnemaire Mireille Rosenstock Julio |
| Info | DIABETES OBESITY & METABOLISM, (2021), vol. 23 br. 6, str. 1221-1231 |
| Projekat | Sanofi, Paris, France |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
